Mass Tort Litigation Regarding Zantac Cancer Cases

As one of the most popular over-the-counter (OTC) medications in the US, millions of people have used Zantac to reduce and relieve their chest pain and heartburn. However, there is a risk of developing cancer from the active ingredient in Zantac, and many other similar medications. There was a mass recall of medications with Ranitidine in them, such as Zantac OTC. This recall was issued by the US Food and Drug Administration (FDA) in 2020. Ranitidine is often contaminated with a chemical called N-Nitrosodimethylamine (NDMA). The FDA classifies this as a probable carcinogen. According to the CDC, NDMA has been linked to severe liver disease, liver cancer, lung cancer, and testicular cancer.

Compensation for Cancer Caused by Zantac

mature woman with cancer from Zantac in headscarfZantac has been used by millions of people in the US for years, without being aware of the potential cancer risk. Sanofi, the manufacturer of Zantac failed to ensure the safety of their product. As such, some customers are suffering from severe cancer or disease. If you or a loved one were diagnosed with cancer after using Zantac, you may be eligible for compensation. All in all, Sanofi must be held accountable for their negligence towards their customer’s health and safety.

Generally, compensation for a Ranitidine cancer suit may include economic damages, such as from past or future medical bills, lost earnings, and pain & suffering. Overall, the compensation a plaintiff is eligible for depends on the unique and specific details of their individual case.

NMDA Contamination and Recalls

An independent lab, Valiasure, discovered the NDMA contamination in 2019. While the FDA investigated, there was a voluntary recall. Zantac and other OTC drugs like it sat on the shelves of many stores until the mandatory recall was announced in April 2020. According to the tests performed, the longer the Ranitidine remained in storage, the higher the NDMA concentration became. Warmer temperatures also contributed to increased contamination. At this time, it is currently unknown how long this contamination has been affecting Ranitidine medications or their users.

Contact Us

If you were diagnosed with cancer after using Zantac OTC or a generic equivalent, D’Agostino & Associates may be able to help you.

At D’Agostino & Associates, our team of lawyers can help you sort through all the details, understand what you are entitled to, and fight to get what you deserve. D’Agostino & Associates P.C. has offices in New York and New Jersey. Contact us, or call us at 1-888-245-2924 to schedule a free consultation with our personal injury attorneys.